Evidence map›Paper›PMID 34296379›Full record

ArticleGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2022

Remission of type 2 diabetes after gastrectomy for gastric cancer: diabetes prediction score.

Yeongkeun Kwon, Jin-Won Kwon, Jane Ha, Dohyang Kim, Jaehyeong Cho, Soo Min Jeon, Shin-Hoo Park, Jinseub Hwang, Nam Hoon Kim, Sungsoo Park

Abstract read
PubMed Publisher
In one paragraph

Article in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Type 2 diabetes in patients undergoing gastric cancer surgery: areas requiring disease-specific glycemic management.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025
    Review
  5. Advances, breakthroughs, and challenges in gastric cancer surgery.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2023
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yeongkeun Kwon *Division of Foregut Surgery, Korea University College of Medicine, Seoul, Korea.
Jin-Won Kwon *BK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Korea.
Jane Ha *Centre for Obesity and Metabolic Diseases, Korea University Anam Hospital, Seoul, Korea.
Dohyang KimDepartment of Statistics, Daegu University, Gyeongbuk, Korea.
Jaehyeong ChoDepartment of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.
Soo Min JeonBK21 FOUR Community-Based Intelligent Novel Drug Discovery Education Unit, College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Korea.
Shin-Hoo ParkDivision of Foregut Surgery, Korea University College of Medicine, Seoul, Korea.
Jinseub HwangDepartment of Statistics, Daegu University, Gyeongbuk, Korea.
Nam Hoon KimDivision of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.
Sungsoo ParkDivision of Foregut Surgery, Korea University College of Medicine, Seoul, Korea. kugspss@korea.ac.kr.ORCID 0000-0002-1779-8683

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough type 2 diabetes (T2D) remission after gastric cancer surgery has been reported, little is known about the predictors of postoperative T2D remission.

methodsThis study used data from a nationwide cohort provided by the National Health Insurance Service in Korea. We developed a diabetes prediction (DP) score, which predicted postoperative T2D remissions using a logistic regression model based on preoperative variables. We applied machine-learning algorithms [random forest, XGboost, and least absolute shrinkage and selection operator (LASSO) regression] and compared their predictive performances with those of the DP score.

resultsThe DP score comprised five parameters: baseline body mass index (< 25 or ≥ 25 kg/m

conclusionsThe DP score is a useful scoring system for predicting T2D remission after gastric cancer surgery.

Indexed as

Diabetes Mellitus, Type 2Stomach NeoplasmsAgedGastrectomyHumansRetrospective StudiesTreatment OutcomeGastrectomyGastric cancerPredictionType 2 diabetes

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.